Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomy

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue SUPPL. 4, 1997, Pages 76-78

  Frank Raue, K ^a   Hoppner W ^b   Buhr, H ^c   Herfarth, Ch ^d   Raue, F ^a  

^a Endokrinologisch Humangenetische G   (Germany)

^b Inst F Hormon F   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Multiple endocrine neoplasia type 2A; Prophylactic thyroidectomy; Ret mutation; Thyroxine replacement therapy

Indexed keywords

CALCITONIN;

ADOLESCENT; CALCITONIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FOLLOW UP; HETEROZYGOTE; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIPPLE SYNDROME; THYROID HYPERPLASIA; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

EID: 0030819208     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211940     Document Type: Conference Paper

References (7)

1. Dralle H, Grimm O, Simon D, Frank-Raue K, Görtz G, Niederle B, Wahl RA, Koch B, Walgenbach S, Hampel R, Ritter MM, Spelsberg F, Heiß A, Hinze P, Höppner W: The German and Austrian experience of prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma. World J Surg, in press, 1997
2. Frank-Raue K, Höppner W, Frilling A, Kotzerke J, Dralle H, Haase R, Mann K, Seif F, Kirchner R, Rendl J, Deckart HF, Ritter MM, Hampel R, Klempa J, Scholz GH, Raue F, and the German Medullary Thyroid Carcinoma Study Group: Mutations in the RET proto-oncogene in German MEN families: relation between genotype and phenotype. J Clin Endocrinol Metab 81: 1780-1783, 1996
3. Frank-Raue K, Höppner W, Ziegler R, Raue F: Genetic testing for mutation in RET proto-oncogene in diagnosis and management of medullary thyroid carcinoma. Exp Clin Endocrinol Diabetes 104 (Suppl. 1): v 73, 1996
4. Lips CJM, Landsvater RM, Höppener JWM, Geerdink RA, Blijham G, Jansen-Schilhorn van Veen JM, van Gils APG, de Wit MJ, Zewald RA, Berends MJH, Beemer FA, Brouwers-Smalbraak J, Jansen RPM, van Amstel HKP, van Vroonhoven TJM, Vroom TM: Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331: 828-835, 1994
5. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2a (MEN 2A). Nature 363: 458-469, 1993
6. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir GM, and tG: RET protooncogene mutations in French MEN 2A and FMTC families. Human Molecular Genetics 3: 1939-1943, 1994
7. Wells SA, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, Norton JA, Donis-Keller H: Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2a. Annals Surgery 220: 237-250, 1994